Wellcome Sanger Institute Best Practice - the Nagoya Protocol and Access and Benefit Sharing (ABS) | ABSCH-A19A20-SCBD-262671 | Model Contractual Clauses, Codes of Conduct, Guidelines, Best Practices and/or Standard | Access and Benefit-Sharing Clearing-House

Loading...
  |  

Model Contractual Clauses, Codes of Conduct, Guidelines, Best Practices and/or Standard (A19A20)

last updated: 12 Dec 2022

General Information
Wellcome Sanger Institute Best Practice - the Nagoya Protocol and Access and Benefit Sharing (ABS)
EN
  • Best practices
Catherine McCarthy - Wellcome Sanger Institute
EN
Wellcome Sanger Institute
EN
2022-05
EN
EN
EN
Access to the resource(s)
Information on the content of the resource
This document has been produced in order to provide assurance to Nagoya Protocol member states, regulators, researchers, collaborators and peers, that the Wellcome Sanger Institute has initiated and carries out appropriate processes and procedures to enable compliance with global Access and Benefit Sharing (hereafter; ABS) measures and compliance with the UK ABS legislation5 implementing the Nagoya Protocol1 for scientific research undertaken. Within this document are the tools, processes and procedures, comprising Institute policy, that when employed correctly staff and associates of the Wellcome Sanger Institute can be confident that they are conducting their research in accordance with the UK ABS legislation and in turn, ABS legislation in force globally.
EN
Keywords for facilitating searching for information in the clearing-houses
  • sectoral
  • transfer/exchange of genetic resources
Loading...